Iqvia Holdings (IQV) Non-Current Debt (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Non-Current Debt came in at $13.7 billion in Q2 2026, down 3.33% year-over-year from $14.2 billion in Q2 2025, and down 2.03% quarter-over-quarter from $14.0 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Non-Current Debt (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Non-Current Debt across 15 years of filings, most recently posting $13.7 billion for Q2 2026.
- In Q2 2026, Non-Current Debt fell 3.33% year-over-year to $13.7 billion; the TTM figure through Jun 2026 stood at $13.7 billion (down 3.33% YoY), while the FY2025 annual figure was $13.9 billion, up 8.15% from the prior year.
- Non-Current Debt came in at $13.7 billion for Q2 2026 at Iqvia Holdings, down from $14.0 billion in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $14.2 billion in Q2 2025 to a low of $11.8 billion in Q1 2023.
- Average Non-Current Debt over 5 years is $12.8 billion, with a median of $12.7 billion recorded in 2022.
- Year-over-year, Non-Current Debt slipped 5.69% in 2023 and gained 17.25% in 2025.
- Over 5 years, Non-Current Debt stood at $12.6 billion in 2022, then gained by 2.86% to $13.0 billion in 2023, then retreated by 0.9% to $12.8 billion in 2024, then advanced by 8.15% to $13.9 billion in 2025, then dropped by 1.29% to $13.7 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Debt figures were $13.7 billion in Q2 2026, $14.0 billion in Q1 2026, and $13.9 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 13.71 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.11 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 2.62 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 1.04 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 481.59 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.71 Bn |
| Mar 31, 2026 | 13.99 Bn |
| Dec 31, 2025 | 13.88 Bn |
| Sep 30, 2025 | 12.79 Bn |
| Jun 30, 2025 | 14.18 Bn |
| Mar 31, 2025 | 13.11 Bn |
| Dec 31, 2024 | 12.84 Bn |
| Sep 30, 2024 | 12.29 Bn |
| Jun 30, 2024 | 12.09 Bn |
| Mar 31, 2024 | 12.82 Bn |
| Dec 31, 2023 | 12.96 Bn |
| Sep 30, 2023 | 12.32 Bn |
| Jun 30, 2023 | 12.43 Bn |
| Mar 31, 2023 | 11.83 Bn |
| Dec 31, 2022 | 12.60 Bn |
| Sep 30, 2022 | 12.24 Bn |
| Jun 30, 2022 | 12.62 Bn |
| Mar 31, 2022 | 12.55 Bn |
| Dec 31, 2021 | 12.03 Bn |
| Sep 30, 2021 | 12.08 Bn |